Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Other2

Role Distribution

Principal Investigator1
Other Roles1
PI Rate50%

Activity Timeline

Clinical Trials (2)

NCT04381364Phase 2Unknown
Inhalation of Ciclesonide for Patients With COVID-19: A Randomised Open Treatment Study (HALT COVID-19)
Covid-19Pneumonia, ViralSars-CoV2
PrincipalinvestigatorStart date: 2020-05-29
Study of Human Adipose Tissue (LOSHAT)
Adipose TissueHumanLipolysis+5 more
StudydirectorStart date: 2018-09-20

Research Network

Collaboration Network

3 collaborators·3 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Peter Arner, MD, PhD

Karolinska University Hospital

Very Similar
1 trials

Shared therapeutic areas:

Adipose TissueHumansLipolysis+5 more

Worked with same sponsors:

Karolinska InstitutetKarolinska University Hospital
Collaborated on 1 trial
Similarity Score84%

Mikael Rydén, Md, PhD

Karolinska University Hospital

Very Similar
1 trials

Shared therapeutic areas:

Adipose TissueHumansLipolysis+5 more

Worked with same sponsors:

Karolinska InstitutetKarolinska University Hospital
Collaborated on 1 trial
Similarity Score84%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

COVID-19SARS-CoV-2Diabetes Mellitus, Type 2+1 more
Similarity Score11%

David Crowley, MD

KGK Science Inc.

Related
54 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2COVID-19Obesity+1 more
Similarity Score11%

Samuel Klein, MD

Washington University School of Medicine

Related
30 trials

Shared therapeutic areas:

ObesityDiabetes Mellitus, Type 2Weight Gain+1 more
Similarity Score11%

Ali MA Ismail, lecturer

Cairo University

Related
27 trials

Shared therapeutic areas:

ObesityWeight Loss
Similarity Score5%

ali ismail, lecturer

Cairo University

Related
29 trials

Shared therapeutic areas:

ObesityDiabetes Mellitus, Type 2
Similarity Score5%

Meral Boşnak Güçlü, Prof. Dr.

Gazi University

Related
22 trials

Shared therapeutic areas:

COVID-19Diabetes Mellitus, Type 2
Similarity Score5%

Helen Heslop, MD

Baylor College of Medicine

Related
17 trials

Shared therapeutic areas:

COVID-19SARS-CoV-2
Similarity Score5%

Andrea Natale, MD

Texas Cardiac Arrhythmia Research Foundation

Related
18 trials

Shared therapeutic areas:

COVID-19Obesity
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT04381364Phase 2PrincipalInvestigator

Inhalation of Ciclesonide for Patients With COVID-19: A Randomised Open Treatment Study (HALT COVID-19)

Covid-19Pneumonia, ViralSars-CoV2
Unknown
NCT03675464StudyDirector

Study of Human Adipose Tissue (LOSHAT)

Adipose TissueHumanLipolysis+5 more
Unknown

All 2 trials loaded